Deere & Company DCO.DE XETRA · Industrials · United States
624.20 € +0.29% +1.80 €
Summary
42 / 100 · Bulios Score
What speaks for it
- It beat profit estimates 8 times in the last 8 quarters.
- It has been profitable 6 years in a row.
What to watch
- Repaying its net debt would take 5.0 years of operating profit.
- The share price is above the Bulios Fair Price.
- Analysts expect revenue to fall by 19% this fiscal year.
- Revenue fell by 3.8% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 38.1 USD for 1 USD of yearly profit. Over the last five years it was 17.4 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 5.6% a year over 5 years. Over the last 3 years it fell by 3.8% a year. For the next fiscal year analysts expect revenue to fall by 19%. Earnings per share fell by 7.4% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 63 USD
- Research and development 5.0 USD
- Sales and administration 12 USD
- Taxes and other 9.3 USD
- Net profit 10 USD
Net profit, industry median (Agricultural - Machinery) 6.9 USD
Out of every 100 USD of revenue, 10 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 19.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 0.90%
- Paid out of profit
- 34%
You receive 5.63 € per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 17
- Hold 17
- Sell 5
No analyst has published a price target.
44% of the analysts recommend buying.
Analysts in detail